Modification Agreements in the Health Care Equipment & Supplies Industry
34 Contracts & Agreements
- Apyx Medical Corp (1 contract)
- CORNERSTONE THERAPEUTICS INC (3)
- DYNATRONICS CORP (3)
- FONAR CORP (1)
- HELIUS MEDICAL TECHNOLOGIES, INC. (2)
- INTROGEN THERAPEUTICS INC (1)
- OxySure Therapeutics, Inc. (17)
- Surmodics, Inc. (6)
- Sixth Modification Agreement, dated January 22, 2020 (DYNATRONICS CORP, Filed With SEC on January 28, 2020)
- Fifth Modification Agreement, dated June 21, 2019 (DYNATRONICS CORP, Filed With SEC on June 26, 2019)
- MODIFICATION AGREEMENT (DYNATRONICS CORP, Filed With SEC on October 6, 2017)
- Modification No. 4 to the CRADA (HELIUS MEDICAL TECHNOLOGIES, INC., Filed With SEC on September 12, 2017)
- Modification No. 3 to the CRADA, dated December 28, 2015 (HELIUS MEDICAL TECHNOLOGIES, INC., Filed With SEC on December 31, 2015)
- MODIFICATION OF AGREEMENT (FIFTH MODIFICATION) (OxySure Therapeutics, Inc., Filed With SEC on April 15, 2014)
- MODIFICATION AND AMENDMENT (FONAR CORP, Filed With SEC on October 15, 2013)
- MODIFICATION OF AGREEMENT (FOURTH MODIFICATION) (OxySure Therapeutics, Inc., Filed With SEC on April 2, 2013)
- FOURTH MODIFICATION OF AGREEMENT (OxySure Therapeutics, Inc., Filed With SEC on March 30, 2012)
- FOURTH MODIFICATION OF AGREEMENT (OxySure Therapeutics, Inc., Filed With SEC on March 30, 2012)
- SECOND MODIFICATION OF AGREEMENT (OxySure Therapeutics, Inc., Filed With SEC on May 27, 2011)
- MODIFICATION OF AGREEMENT (OxySure Therapeutics, Inc., Filed With SEC on January 13, 2011)
- Medical Device, comprised of surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, as well as drug delivery... (Surmodics, Inc., Filed With SEC on December 14, 2010)
- MODIFICATION OF AGREEMENT (OxySure Therapeutics, Inc., Filed With SEC on October 5, 2010)
- THIRD MODIFICATION OF AGREEMENT (OxySure Therapeutics, Inc., Filed With SEC on October 5, 2010)
- THIRD MODIFICATION OF AGREEMENT (OxySure Therapeutics, Inc., Filed With SEC on October 5, 2010)
- MODIFICATION OF AGREEMENT (THIRD MODIFICATION) (OxySure Therapeutics, Inc., Filed With SEC on July 15, 2010)
- Modification Agreement (Cover Page) (Apyx Medical Corp, Filed With SEC on March 15, 2010)
- Cardiovascular, supporting the drug delivery and surface modification needs of our cardiovascular customers by providing drug delivery polymers and coating technologies including... (Surmodics, Inc., Filed With SEC on December 11, 2009)
- Cardiovascular, supporting the drug delivery and surface modification needs of our cardiovascular customers by providing drug delivery polymers and coating technologies including... (Surmodics, Inc., Filed With SEC on December 11, 2009)
- Cardiovascular, supporting the drug delivery and surface modification needs of our cardiovascular customers by providing drug delivery polymers and coating technologies including... (Surmodics, Inc., Filed With SEC on December 11, 2009)
- Cardiovascular, supporting the drug delivery and surface modification needs of our cardiovascular customers by providing drug delivery polymers and coating technologies including... (Surmodics, Inc., Filed With SEC on December 11, 2009)
- Cardiovascular, supporting the drug delivery and surface modification needs of our cardiovascular customers by providing drug delivery polymers and coating technologies including... (Surmodics, Inc., Filed With SEC on December 11, 2009)
- MODIFICATION OF AGREEMENT (OxySure Therapeutics, Inc., Filed With SEC on August 12, 2009)
- MODIFICATION OF AGREEMENT (OxySure Therapeutics, Inc., Filed With SEC on August 12, 2009)
- SECOND MODIFICATION OF AGREEMENT (OxySure Therapeutics, Inc., Filed With SEC on August 12, 2009)
- MODIFICATION OF AGREEMENT (OxySure Therapeutics, Inc., Filed With SEC on August 12, 2009)
- MODIFICATION OF AGREEMENT (OxySure Therapeutics, Inc., Filed With SEC on August 12, 2009)
- MODIFICATION OF AGREEMENT (OxySure Therapeutics, Inc., Filed With SEC on August 12, 2009)
- MODIFICATION OF AGREEMENT (OxySure Therapeutics, Inc., Filed With SEC on August 12, 2009)
- Ex-10.46 Modification Agreement, dated June 25, 2008 (CORNERSTONE THERAPEUTICS INC, Filed With SEC on November 5, 2008)
- Ex-10.44 Modification Agreement, dated July 31, 2007 (CORNERSTONE THERAPEUTICS INC, Filed With SEC on November 5, 2008)
- Ex-10.43 Modification Agreement, dated April 10, 2006 (CORNERSTONE THERAPEUTICS INC, Filed With SEC on November 5, 2008)
- Modification Agreement (INTROGEN THERAPEUTICS INC, Filed With SEC on August 16, 2004)
